Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 Jan;75(1):76–81.

Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.

J Bariety 1, N Hinglais 1, S Bhakdi 1, C Mandet 1, M Rouchon 1, M D Kazatchkine 1
PMCID: PMC1541855  PMID: 2467771

Abstract

The localization of S protein (Vitronectin) antigen was studied by indirect immunofluorescence and immunoelectron microscopy in normal adult human kidneys and in biopsy specimens from patients with a wide range of renal diseases, and compared with that of neoantigens of the C5b-9 terminal complement complex. S protein antigen was diffusely present in arteriolar perimyocytic matrices, the glomerular basement membrane and mesangial matrix, and tubular basement membranes in the cortex of normal and diseased kidneys without superimposable staining for C5b-9 neoantigens. Cell remnants embedded in normal and sclerotic extracellular matrices expressed S protein antigen and also stained for C5b-9 neoantigens. Several lines of evidence suggested that S protein present in connective matrices most likely represents S protein or C5b-9 complexes trapped from the circulation. Glomerular immune deposits and arteriolar hyalin deposits which contained C5b-9 neoantigens also contained S protein antigen in the same location. In a few specimens from patients with membranous nephritis stage I and IgA nephropathy, immune deposits contained neither detectable C5b-9 neoantigens nor S protein. The observed strong co-staining of immune deposits for S-protein and C5b-9 caution against the generalization that C5b-9 within glomerular immune deposits represent membrane-bound cytolytic complement complexes.

Full text

PDF
76

Images in this article

78Fig. 5
on p.78

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler S., Baker P. J., Pritzl P., Couser W. G. Detection of terminal complement components in experimental immune glomerular injury. Kidney Int. 1984 Dec;26(6):830–837. doi: 10.1038/ki.1984.225. [DOI] [PubMed] [Google Scholar]
  2. Bariéty J., Druet P., Laliberté F., Sapin C., Belair M. F., Paing M. Ultrastructural evidence, by immunoperoxidase technique, for a tubular reabsoprtion of endogenous albumin in normal rat. Lab Invest. 1978 Feb;38(2):175–180. [PubMed] [Google Scholar]
  3. Bhakdi S., Muhly M. A simple immunoradiometric assay for the terminal SC5b-9 complex of human complement. J Immunol Methods. 1983 Feb 25;57(1-3):283–289. doi: 10.1016/0022-1759(83)90088-1. [DOI] [PubMed] [Google Scholar]
  4. Bhakdi S., Tranum-Jensen J. Membrane damage by complement. Biochim Biophys Acta. 1983 Aug 11;737(3-4):343–372. doi: 10.1016/0304-4157(83)90006-0. [DOI] [PubMed] [Google Scholar]
  5. Dahlbäck K., Löfberg H., Dahlbäck B. Localization of vitronectin (S-protein of complement) in normal human skin. Acta Derm Venereol. 1986;66(6):461–467. [PubMed] [Google Scholar]
  6. Druet P., Bariéty J., Laliberté F., Bellon B., Belair M. F., Paing M. Distribution of heterologous antiperoxidase antibodies and their fragments in the superficial renal cortex of normal Wistar-Munich rat: an ultrastructural study. Lab Invest. 1978 Dec;39(6):623–631. [PubMed] [Google Scholar]
  7. Edelman G. M. Cell adhesion and the molecular processes of morphogenesis. Annu Rev Biochem. 1985;54:135–169. doi: 10.1146/annurev.bi.54.070185.001031. [DOI] [PubMed] [Google Scholar]
  8. Falk R. J., Dalmasso A. P., Kim Y., Tsai C. H., Scheinman J. I., Gewurz H., Michael A. F. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease. J Clin Invest. 1983 Aug;72(2):560–573. doi: 10.1172/JCI111004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Falk R. J., Podack E., Dalmasso A. P., Jennette J. C. Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue. Am J Pathol. 1987 Apr;127(1):182–190. [PMC free article] [PubMed] [Google Scholar]
  10. Falk R. J., Sisson S. P., Dalmasso A. P., Kim Y., Michael A. F., Vernier R. L. Ultrastructural localization of the membrane attack complex of complement in human renal tissues. Am J Kidney Dis. 1987 Feb;9(2):121–128. doi: 10.1016/s0272-6386(87)80089-6. [DOI] [PubMed] [Google Scholar]
  11. Groggel G. C., Salant D. J., Darby C., Rennke H. G., Couser W. G. Role of terminal complement pathway in the heterologous phase of antiglomerular basement membrane nephritis. Kidney Int. 1985 Apr;27(4):643–651. doi: 10.1038/ki.1985.59. [DOI] [PubMed] [Google Scholar]
  12. Hayman E. G., Pierschbacher M. D., Ohgren Y., Ruoslahti E. Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc Natl Acad Sci U S A. 1983 Jul;80(13):4003–4007. doi: 10.1073/pnas.80.13.4003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hinglais N., Kazatchkine M. D., Bhakdi S., Appay M. D., Mandet C., Grossetete J., Bariety J. Immunohistochemical study of the C5b-9 complex of complement in human kidneys. Kidney Int. 1986 Sep;30(3):399–410. doi: 10.1038/ki.1986.198. [DOI] [PubMed] [Google Scholar]
  14. Holmes R. Preparation from human serum of an alpha-one protein which induces the immediate growth of unadapted cells in vitro. J Cell Biol. 1967 Feb;32(2):297–308. doi: 10.1083/jcb.32.2.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hugo F., Krämer S., Bhakdi S. Sensitive ELISA for quantitating the terminal membrane C5b-9 and fluid-phase SC5b-9 complex of human complement. J Immunol Methods. 1987 May 20;99(2):243–251. doi: 10.1016/0022-1759(87)90134-7. [DOI] [PubMed] [Google Scholar]
  16. Jenne D., Hugo F., Bhakdi S. Interaction of complement S-protein with thrombin-antithrombin complexes: a role for the S-protein in haemostasis. Thromb Res. 1985 May 15;38(4):401–412. doi: 10.1016/0049-3848(85)90138-0. [DOI] [PubMed] [Google Scholar]
  17. Jenne D., Hugo F., Bhakdi S. Monoclonal antibodies to human plasma protein X alias complement S-protein. Biosci Rep. 1985 Apr;5(4):343–352. doi: 10.1007/BF01116907. [DOI] [PubMed] [Google Scholar]
  18. Jenne D., Stanley K. K. Molecular cloning of S-protein, a link between complement, coagulation and cell-substrate adhesion. EMBO J. 1985 Dec 1;4(12):3153–3157. doi: 10.1002/j.1460-2075.1985.tb04058.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Parra G., Platt J. L., Falk R. J., Rodriguez-Iturbe B., Michael A. F. Cell populations and membrane attack complex in glomeruli of patients with post-streptococcal glomerulonephritis: identification using monoclonal antibodies by indirect immunofluorescence. Clin Immunol Immunopathol. 1984 Dec;33(3):324–332. doi: 10.1016/0090-1229(84)90303-9. [DOI] [PubMed] [Google Scholar]
  20. Perkinson D. T., Baker P. J., Couser W. G., Johnson R. J., Adler S. Membrane attack complex deposition in experimental glomerular injury. Am J Pathol. 1985 Jul;120(1):121–128. [PMC free article] [PubMed] [Google Scholar]
  21. Podack E. R., Müller-Eberhard H. J. Binding of desoxycholate, phosphatidylcholine vesicles, lipoprotein and of the S-protein to complexes of terminal complement components. J Immunol. 1978 Sep;121(3):1025–1030. [PubMed] [Google Scholar]
  22. Preissner K. T., Wassmuth R., Müller-Berghaus G. Physicochemical characterization of human S-protein and its function in the blood coagulation system. Biochem J. 1985 Oct 15;231(2):349–355. doi: 10.1042/bj2310349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rauterberg E. W., Lieberknecht H. M., Wingen A. M., Ritz E. Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis. Kidney Int. 1987 Mar;31(3):820–829. doi: 10.1038/ki.1987.72. [DOI] [PubMed] [Google Scholar]
  24. Schäfer H., Mathey D., Hugo F., Bhakdi S. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J Immunol. 1986 Sep 15;137(6):1945–1949. [PubMed] [Google Scholar]
  25. Suzuki S., Oldberg A., Hayman E. G., Pierschbacher M. D., Ruoslahti E. Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J. 1985 Oct;4(10):2519–2524. doi: 10.1002/j.1460-2075.1985.tb03965.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tomino Y., Yagame M., Eguchi K., Nomoto Y., Sakai H. Immunofluorescent studies on S-protein in glomeruli from patients with IgA nephropathy. Am J Pathol. 1987 Nov;129(2):402–406. [PMC free article] [PubMed] [Google Scholar]
  27. de Heer E., Daha M. R., Bhakdi S., Bazin H., van Es L. A. Possible involvement of terminal complement complex in active Heymann nephritis. Kidney Int. 1985 Feb;27(2):388–393. doi: 10.1038/ki.1985.21. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES